Inspire Medical Systems (NYSE: INSP) reported Q2 EPS of $0.45, $0.24 better than the analyst estimate of $0.21. Revenue for the quarter came in at $217.1 million versus the consensus estimate of $214.48 million.

GUIDANCE:

Inspire Medical Systems sees FY2025 EPS of $0.40-$0.50, versus the consensus of $2.25. Inspire Medical Systems sees FY2025 revenue of $900-910 million, versus the consensus of $946.4 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.